Drugs: R

Rolapitant

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Neurokinin 1 Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Substance P/Neurokinin-1 Receptor Antagonist [EPC]

0 identified pills

Ropinirole

A non-ergoline dopamine agonist" with "high relative in vitro specificity and full intrinsic activity at the D2 and D3 dopamine receptor subtypes." In Parkinson's disease its benefit is believed to involve "stimulation of postsynaptic dopamine D2-type receptors within the caudate-putamen in the brain.

311 identified pills

Rosuvastain Calcium

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

0 identified pills

Rosuvastatin

HMG Co-A reductase inhibitor (statin)" that inhibits "the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol.

353 identified pills

rabeprazole sodium

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

0 identified pills

regorafenib

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]

0 identified pills

rehmannia root, angelica gigas root

Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]

0 identified pills

relugolix, estradiol hemihydrate, and norethindrone acetate

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Estradiol Congeners [CS]; Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]; Progesterone Congeners [CS]; Progestin [EPC]

0 identified pills

revumenib

Menin Inhibitor [EPC]; Menin Inhibitors [MoA]

0 identified pills

ribociclib

Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

0 identified pills

rifaximin

Rifamycin Antibacterial [EPC]; Rifamycins [CS]

0 identified pills

riociguat

Guanylate Cyclase Stimulators [MoA]; Soluble Guanylate Cyclase Stimulator [EPC]

0 identified pills

ritlecitinib

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Janus Kinase 3 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]

0 identified pills

ritonavir 100 mg

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Protease Inhibitor [EPC]; UDP Glucuronosyltransferases Inducers [MoA]

0 identified pills

ropinirole hydrochloride

Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]

0 identified pills

rucaparib

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

0 identified pills

ruxolitinib

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]

0 identified pills